Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CG Oncology, Inc.(CGON) | 2,221,474 | 2,221,474 | 0 | 92,236 | 150,349 | 32.67% | +58,114 |
| ALUMIS INC. | 4,247,670 | 4,247,670 | 0 | 41,457 | 93,576 | 20.33% | +52,119 |
| Centessa Pharmaceuticals plc | 1,364,019 | 1,364,019 | 0 | 34,114 | 54,179 | 11.77% | +20,065 |
| Corvus Pharmaceuticals, Inc.(CRVS) | 1,381,233 | 1,831,233 | +450,000 | 10,635 | 26,791 | 5.82% | +16,155 |
| Minerva Neurosciences, Inc. | 0 | 1,986,600 | +1,986,600 | 0 | 11,969 | 2.60% | +11,969 |
| Celldex Therapeutics, Inc.(CLDX) | 0 | 315,913 | +315,913 | 0 | 10,021 | 2.18% | +10,021 |
| AtaiBeckley Inc.(ATAI) | 0 | 2,750,000 | +2,750,000 | 0 | 9,735 | 2.12% | +9,735 |
| Crinetics Pharmaceuticals, Inc.(CRNX) | 0 | 212,010 | +212,010 | 0 | 7,700 | 1.67% | +7,700 |
| Denali Therapeutics Inc.(DNLI) | 1,000,000 | 1,209,971 | +209,971 | 16,510 | 23,231 | 5.05% | +6,721 |
| OnKure Therapeutics, Inc. | 0 | 1,445,783 | +1,445,783 | 0 | 5,986 | 1.30% | +5,986 |
| Jade Biosciences, Inc. | 0 | 320,000 | +320,000 | 0 | 4,496 | 0.98% | +4,496 |
| GH Research PLC(GHRS) | 0 | 315,492 | +315,492 | 0 | 4,436 | 0.96% | +4,436 |
| AGIOS PHARMACEUTICALS, INC.(AGIO) | 530,000 | 525,000 | -5,000 | 14,427 | 17,761 | 3.86% | +3,334 |
| Zura Bio Ltd | 0 | 450,000 | +450,000 | 0 | 2,678 | 0.58% | +2,678 |
| Hinge Health, Inc.(HNGE) | 135,000 | 220,400 | +85,400 | 6,271 | 8,499 | 1.85% | +2,228 |
| Kymera Therapeutics, Inc.(KYMR) | 146,332 | 146,332 | 0 | 11,386 | 12,188 | 2.65% | +802 |
| Verastem, Inc. | 3,135,120 | 3,146,631 | +11,511 | 24,203 | 16,677 | 3.62% | -7,526 |
| Atai Beckley N.V. | 2,750,000 | 0 | -2,750,000 | 11,248 | 0 | — | -11,247 |
| Natera, Inc.(NTRA) | 67,356 | 0 | -67,356 | 15,431 | 0 | — | -15,431 |
| RAPT Therapeutics, Inc. | 1,562,500 | 0 | -1,562,500 | 52,922 | 0 | — | -52,922 |